2021 American Transplant Congress
Trends of Kidney Transplant Volume During Covid-19 Era
*Purpose: The emergence of SARS-CoV-2 and the clinical syndrome of COVID-19 have significantly disrupted routine healthcare and life-saving procedures, including solid organ transplantation. This resulted…2021 American Transplant Congress
High Levels of Sars-cov-2 Detected in Immunosuppressed Covid-19 Patient Environments Weeks Following Initial Positive Test
*Purpose: COVID-19 is a novel viral illness associated with significantly worse mortality, prolonged disease course, and extended periods of viral shedding in transplant patients on…2021 American Transplant Congress
Liver Transplantation Following Checkpoint Inhibitor Therapy – Timing is Everything
*Purpose: Use of checkpoint inhibitors (CPI) prior to liver transplantation has not been well studied and limited case reports describe a risk of early graft…2021 American Transplant Congress
Survey of Transplantation Providers to Assess for Implicit Bias at a Single Center
*Purpose: At our institution’s Center for Transplantation, the Implicit Bias Working Group (IBWG), was formed with the aim to comprehend how implicit biases impact the…2021 American Transplant Congress
Transplant Data Platform – An Augmented Clinical Intelligence Framework
*Purpose: UNOS, SRTR, USRDS registries are rich in patient baseline data. However, all suffer from data attrition as patients move further out post-transplant or between…2021 American Transplant Congress
Clinical Analysis of the Prognosis After Receiving a Liver Graft That Abandoned Transplantation Due to Poor Graft Conditions in the Centers Allocated as a Priority
*Purpose: LT has the limitation of lack of donors compared to those waiting for a transplant. Depending on the recipient's condition, even liver grafts with…2021 American Transplant Congress
No Benefit of Antithymocyte Globulin in Living Donor Liver Transplant Recipients
Baylor University Medical Center, Dallas, TX
*Purpose: Acute rejection after liver transplant is associated with increased risk of graft failure and mortality. Reports on rejection rates in living donor liver transplants…2021 American Transplant Congress
The Landscape of Non-Directed Living Liver Donation in the United States
Johns Hopkins University, Baltimore, MD
*Purpose: Non-directed donation (NDD) for kidney transplantation has increased substantially over the past decade, however the landscape of NDD for liver transplantation has yet not…2021 American Transplant Congress
Long-term Outcomes of Donation After Cardiac Death and Living Donor Liver Transplant for Primary Sclerosing Cholangitis: An Analysis of UNOS Registry from 2002-2020
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Use of donation after circulatory death (DCD) grafts is a reported risk factor for worse outcomes after liver transplant (LT) for primary sclerosing cholangitis…2021 American Transplant Congress
Outcomes of DCD Allografts in Liver Transplant Recipients with HCC
*Purpose: Early studies demonstrated inferior survival for liver transplant (LT) recipients with hepatocellular carcinoma (HCC) who received allografts from donation after cardiac death (DCD) donors…
- « Previous Page
- 1
- …
- 215
- 216
- 217
- 218
- 219
- …
- 1683
- Next Page »